Mannatech (NASDAQ:MTEX) Coverage Initiated by Analysts at StockNews.com

Equities researchers at StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEXGet Free Report) in a note issued to investors on Tuesday. The firm set a “buy” rating on the stock.

Mannatech Price Performance

Shares of MTEX stock opened at $9.81 on Tuesday. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.25 and a quick ratio of 0.74. The firm’s 50-day moving average is $11.74 and its two-hundred day moving average is $10.00. Mannatech has a 12 month low of $6.75 and a 12 month high of $16.49. The company has a market capitalization of $18.49 million, a PE ratio of -12.11 and a beta of 1.06.

Mannatech Company Profile

(Get Free Report)

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.

Featured Articles

Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.